Suppr超能文献

果蝇DNA聚合酶dpoleta和dpoliota对DNA损伤的诱变和非诱变绕过

Mutagenic and nonmutagenic bypass of DNA lesions by Drosophila DNA polymerases dpoleta and dpoliota.

作者信息

Ishikawa T, Uematsu N, Mizukoshi T, Iwai S, Iwasaki H, Masutani C, Hanaoka F, Ueda R, Ohmori H, Todo T

机构信息

Radiation Biology Center, Kyoto University, Kyoto 606-8501, Japan.

出版信息

J Biol Chem. 2001 May 4;276(18):15155-63. doi: 10.1074/jbc.M009822200. Epub 2001 Jan 31.

Abstract

cDNA sequences were identified and isolated that encode Drosophila homologues of human Rad30A and Rad30B called drad30A and drad30B. Here we show that the C-terminal-truncated forms of the drad30A and drad30B gene products, designated dpoletaDeltaC and dpoliotaDeltaC, respectively, exhibit DNA polymerase activity. dpoletaDeltaC and dpoliotaDeltaC efficiently bypass a cis-syn-cyclobutane thymine-thymine (TT) dimer in a mostly error-free manner. dpoletaDeltaC shows limited ability to bypass a 6-4-photoproduct ((6-4)PP) at thymine-thymine (TT-(6-4)PP) or at thymine-cytosine (TC-(6-4)PP) in an error-prone manner. dpoliotaDeltaC scarcely bypasses these lesions. Thus, the fidelity of translesion synthesis depends on the identity of the lesion and on the polymerase. The human XPV gene product, hpoleta, bypasses cis-syn-cyclobutane thymine-thymine dimer efficiently in a mostly error-free manner but does not bypass TT-(6-4)PP, whereas Escherichia coli DNA polymerase V (UmuD'(2)C complex) bypasses both lesions, especially TT-(6-4)PP, in an error-prone manner (Tang, M., Pham, P., Shen, X., Taylor, J. S., O'Donnell, M., Woodgate, R., and Goodman, M. F. (2000) Nature 404, 1014-1018). Both dpoletaDeltaC and DNA polymerase V preferentially incorporate GA opposite TT-(6-4)PP. The chemical structure of the lesions and the similarity in the nucleotides incorporated suggest that structural information in the altered bases contribute to nucleotide selection during incorporation opposite these lesions by these polymerases.

摘要

已鉴定并分离出编码人类Rad30A和Rad30B的果蝇同源物(分别称为drad30A和drad30B)的cDNA序列。在此我们表明,drad30A和drad30B基因产物的C末端截短形式,分别命名为dpoletaDeltaC和dpoliotaDeltaC,具有DNA聚合酶活性。dpoletaDeltaC和dpoliotaDeltaC能以基本无差错的方式有效绕过顺式-环丁烷胸腺嘧啶-胸腺嘧啶(TT)二聚体。dpoletaDeltaC以易错的方式绕过胸腺嘧啶-胸腺嘧啶(TT-(6-4)PP)或胸腺嘧啶-胞嘧啶(TC-(6-4)PP)处的6-4光产物((6-4)PP)的能力有限。dpoliotaDeltaC几乎不能绕过这些损伤。因此,跨损伤合成的保真度取决于损伤的类型和聚合酶。人类XPV基因产物hpoleta能以基本无差错的方式有效绕过顺式-环丁烷胸腺嘧啶-胸腺嘧啶二聚体,但不能绕过TT-(6-4)PP,而大肠杆菌DNA聚合酶V(UmuD'(2)C复合物)以易错的方式绕过这两种损伤,尤其是TT-(6-4)PP(Tang, M., Pham, P., Shen, X., Taylor, J. S., O'Donnell, M., Woodgate, R., and Goodman, M. F. (2000) Nature 404, 1014 - 1018)。dpoletaDeltaC和DNA聚合酶V都优先在TT-(6-4)PP的对面掺入GA。损伤的化学结构以及掺入核苷酸的相似性表明,改变碱基中的结构信息有助于这些聚合酶在这些损伤对面掺入时进行核苷酸选择。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验